合成路线1
该中间体在本合成路线中的序号:
The cyclization of 2-aminobenzophenone (I) with 3-amino-2-chloropyridine (II) by means of NaOH in methylene chloride-water gives 6-phenyl-11H-[2,3-b][1,4]benzodiazepine (III), which is then condensed with (3-chloropropyl)dimethylamine by means of NaH in hot DMF, followed by a treatment with fumaric acid in isopropanol.
【1】
Taylor, C.R.Jr. (A.H. Robins Co. Inc.); Pyridol [1,4] benzodiazepines phenyl-substituees et leurs intermediares, utiles comme medicaments antidepresseurs. BE 0891666; FR 2515183; JP 58065290 .
|
【2】
Serradell, M.N.; Castaner, J.; Souto, M.E.; AHR-9377. Drugs Fut 1984, 9, 3, 163.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
21101 |
(2-aminophenyl)(phenyl)methanone; 2-Aminobenzophenone
|
2835-77-0 |
C13H11NO |
详情 | 详情
|
(II) |
11160 |
2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine
|
6298-19-7 |
C5H5ClN2 |
详情 | 详情
|
(III) |
30304 |
6-phenyl-11H-pyrido[2,3-b][1,4]benzodiazepine
|
|
C18H13N3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
The reaction of 1-(p-benzyloxyphenoxy)-2,3-epoxypropane (I) with 4-[N-(2-aminoethyl)carbamoyl]morpholine (II) by means of KOH in isopropanol gives 1-(p-benzyloxyphenoxy)-3-[2-(morpholinocarbonamido)ethylamino]-2-propanol (III), which is debenzylated by treatment with H2 over Pd/C in ethanol acetic acid and treated with a solution of fumaric acid in ethanol.
【1】
Main, B.G.; Barlow, J.J. (AstraZeneca plc); Morpholine carboxamides and use thereof. FR 2391997; JP 53147038; US 4143140; US 4172150 .
|
【2】
Blancafort, P.; Serradell, M.N.; Thorpe, P.J.; Castaner, J.; ICI-118,587. Drugs Fut 1982, 7, 8, 571.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
32152 |
Benzyl 4-(2-oxiranyloxy)phenyl ether; 2-[4-(Benzyloxy)phenoxy]oxirane; 1-(p-Benzyloxyphenoxy)-2,3-epoxypropane
|
|
C15H14O3 |
详情 |
详情
|
(II) |
32153 |
N-(2-aminoethyl)-4-morpholinecarboxamide; 4-[N-(2-Aminoethyl)carbamoyl]morpholine
|
|
C7H15N3O2 |
详情 |
详情
|
(III) |
32154 |
N-[2-([3-[4-(Benzyloxy)phenoxy]-2-hydroxypropyl]amino)ethyl]-4-morpholinecarboxamide; 1-(p-Benzyloxyphenoxy)-3-[2-(morpholinocarbonamido)ethylamino]-2-propanol
|
|
C23H31N3O5 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
The synthesis of [14C]-labeled BRL-26830A has been described:
The reaction of copper sulfate (I) with sodium methabisulfite, followed by treatment with [14C]-labeled potassium cyanide (II) yields cuprous cyanide (III), which is condensed with methyl 4-bromobenzoate (IV) to afford methyl 4-cyanobenzoate (V). The reduction of (V) with Al/Ni and formic acid gives methyl 4-formylbenzoate (VI), which is condensed with nitroethane by means of butylamine and acetic acid in benzene to give methyl 4-(2-nitro-1-propenyl)benzoate (VII). The treatment of (VII) with Fe and HCl in refluxing methanol yields methyl 4-(acetonyl)benzoate (VIII), which is reductocondensed with (R*)-2-amino-1-phenylethanol (IX) by means of NaBH4 in refluxing benzene and crystallized in methanol to fractionate the optical diastereomers. Finally, the (R*,R*)-isomer (X) is treated with fumaric acid.
【1】
Freer, R.; Morecombe, D.J.; The synthesis of [14C]BRL 26830A, a novel beta-adrenoceptor agonist. J Label Compd Radiopharm 1992, 31, 9, 697.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(IV) |
10168 |
4-Bromobenzoic acid methyl ester; methyl 4-bromobenzoate
|
619-42-1 |
C8H7BrO2 |
详情 | 详情
|
(V) |
10169 |
methyl 4-cyanobenzoate;4-Cyanobenzoic acid methyl ester |
1129-35-7 |
C9H7NO2 |
详情 | 详情
|
(V) |
44596 |
methyl 4-cyanobenzoate
|
|
C9H7NO2 |
详情 |
详情
|
(VI) |
10170 |
methyl 4-formylbenzoate
|
1571-08-0 |
C9H8O3 |
详情 | 详情
|
(VI) |
44597 |
methyl 4-formylbenzoate
|
|
C9H8O3 |
详情 |
详情
|
(VII) |
10171 |
methyl 4-[(Z)-2-nitro-1-propenyl]benzoate
|
|
C11H11NO4 |
详情 |
详情
|
(VII) |
44598 |
methyl 4-[(Z)-2-nitro-1-propenyl]benzoate
|
|
C11H11NO4 |
详情 |
详情
|
(VIII) |
10172 |
methyl 4-(2-oxopropyl)benzoate
|
|
C11H12O3 |
详情 |
详情
|
(VIII) |
44599 |
methyl 4-(2-oxopropyl)benzoate
|
|
C11H12O3 |
详情 |
详情
|
(IX) |
10173 |
(1R)-2-Amino-1-phenyl-1-ethanol
|
2549-14-6 |
C8H11NO |
详情 | 详情
|
(X) |
44595 |
methyl 4-((2R)-2-[[(2R)-2-hydroxy-2-phenylethyl]amino]propyl)benzoate
|
|
C19H23NO3 |
详情 |
详情
|
(X) |
44600 |
methyl 4-((2R)-2-[[(2R)-2-hydroxy-2-phenylethyl]amino]propyl)benzoate
|
|
C19H23NO3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(III) By condensation of 2-hydroxy-2-phenylethylamine (I) with 1-(4-methoxycarbonylphenyl)-2-propanone (II) in refluxing benzene, followed by reduction with NaBH4 in methanol, and treatment with maleic acid (III).
【1】
Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Secondary amines, their preparation and use in pharmaceutical compositions. DE 2965655; EP 0006735; JP 8009085; US 4478849; US 4654371 .
|
【2】
Serradell, M.N.; Castaner, J.; BRL-26830A. Drugs Fut 1985, 10, 3, 188.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29041 |
2-amino-1-phenyl-1-ethanol
|
7568-93-6 |
C8H11NO |
详情 | 详情
|
(II) |
10172 |
methyl 4-(2-oxopropyl)benzoate
|
|
C11H12O3 |
详情 |
详情
|
(III) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) Elimoclavine (I) obtained by fermentation is first O-mesylated and then the mesyl group in the product (II) displaced by 2-aminoethanol to give the hydroxyethylamino derivative (III). Repeated acylation of (III) with mesyl chloride affords the N,O-dimesylate (IV), which exchanges the O-mesyl group for an azido group on treatment with sodium azide to give the base (VI). Salt formation with maleic acid gives RGH-7825 (1,2).
【1】
Mago, N.K.E.; et al. (Gedeon Richter Ltd.); Novel ergol-8-ene and ergolin compounds and process for preparing same. DE 3026271; HU 180467 .
|
【2】
Nogradi, M.; RGH-7825. Drugs Fut 1985, 10, 9, 753.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(A) |
27347 |
N,N-dicyclohexylamine
|
101-83-7 |
C12H23N |
详情 | 详情
|
(I) |
27346 |
[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methanol
|
|
C16H18N2O |
详情 |
详情
|
(II) |
27348 |
[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl methanesulfonate
|
|
C17H20N2O3S |
详情 |
详情
|
(III) |
27349 |
2-([[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]amino)-1-ethanol
|
|
C18H23N3O |
详情 |
详情
|
(IV) |
27350 |
2-[[[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl](methylsulfonyl)amino]ethyl methanesulfonate
|
|
C20H27N3O5S2 |
详情 |
详情
|
(V) |
27351 |
N-[[(6aR,10aR)-7-methyl-4,6,6a,7,8,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]-N-(2-azidoethyl)methanesulfonamide
|
|
C19H24N6O2S |
详情 |
详情
|
(VI) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(B) Compound can be prepared in two different ways:
1) The Sandmeyer reaction of 2-amino-5-nitro-2'-chlorobenzophenone (I) with HCl, NaNO2 and CuCl gives 2,2'-dichloro-5-nitrobenzophenone (II), which is condensed with 2-diethylaminomethylimidazole (III) by means of NaH in DMF to afford the free base of Y-9179 (IV). Finally, this compound is treated with fumaric acid (B).
2) The treatment of 1-[2-(2-chlorobenzoyl)-4-nitrophenyl]-2-hydroxymethyl-imidazole (V) with SOCl2 gives the corresponding 2-chloromethyl derivative (VI), which is then treated with diethylamine (A) and Na2CO3 in benzene-DMF at 60 C.
【1】
Nakanishi, M.; et al. (Welfide Corporation); 1-[2-(2-Chlorobenzoyl)-4-nitrophenyl]-2-(diethylaminomethyl)imidazole. US 3915981 .
|
【2】
Roberts, P.J.; Castaner, J.; Y-9179. Drugs Fut 1979, 4, 2, 148.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(A) |
24486 |
Diethylamine; N,N-Diethylamine
|
109-89-7 |
C4H11N |
详情 | 详情
|
(I) |
33258 |
2-Amino-2'-chloro-5-nitrobenzophenone; (2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone; 2-Amino-5-nitro-2'-chlorobenzophenone
|
2011-66-7 |
C13H9ClN2O3 |
详情 | 详情
|
(II) |
33259 |
(2-Chloro-5-nitrophenyl)(2-chlorophenyl)methanone; 2,2'-Dichloro-5-nitrobenzophenone
|
|
C13H7Cl2NO3 |
详情 |
详情
|
(III) |
33260 |
N,N-diethyl-N-(1H-imidazol-2-ylmethyl)amine; 2-Diethylaminomethylimidazole; N-ethyl-N-(1H-imidazol-2-ylmethyl)-1-ethanamine
|
|
C8H15N3 |
详情 |
详情
|
(IV) |
33261 |
(2-chlorophenyl)(2-[2-[(diethylamino)methyl]-1H-imidazol-1-yl]-5-nitrophenyl)methanone
|
|
C21H21ClN4O3 |
详情 |
详情
|
(V) |
33262 |
1-[2-(2-Chlorobenzoyl)-4-nitrophenyl]-2-hydroxymethyl-imidazole; (2-Chlorophenyl)[2-[2-(hydroxymethyl)-1H-imidazol-1-yl]-5-nitrophenyl]methanone
|
|
C17H12ClN3O4 |
详情 |
详情
|
(VI) |
33263 |
[2-[2-(chloromethyl)-1H-imidazol-1-yl]-5-nitrophenyl](2-chlorophenyl)methanone
|
|
C17H11Cl2N3O3 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(B) The reaction of cyclopentene oxide (I) with dimethylamine (II) gives 2-(dimethylamino)cyclopentanol (III), which is treated with methanesulfonyl chloride and NaH in THF to afford the corresponding methasulfonyl ester (IV). The condensation of (IV) with 3,4-dichloroaniline (V) in THF yields N,N-dimethyl-N'-(3,4-dichlorophenyl)cyclopentane-1,2-diamine (VI), which is acylated with propionic anhydride (A) and treated finally with maleic acid (B).
【1】
Szmuszkovicz, J.; N-(2-Aminocyclopentyl)acylanilides and treating depression. BE 0861351; BE 0861355; US 4156015 .
|
【2】
Szmuszkovicz, J.; Composes alcanoylanilides et leur preparation. BE 0875461 .
|
【3】
Szmuszkovicz, J.; N-(2-aminocyclopentyl)amides. BE 0867554; DE 2817112; FR 2416882; GB 1581914; JP 54106451; NL 7803442 .
|
【4】
Szmuszkovicz, J.; Anilide derivatives as antidepressants. US 4128663; US 4148913 .
|
【5】
Szmuszkovicz, J.; N-(2-Aminocyclopentyl)acylanilides and treating depression. US 4156733; US 4157398 .
|
【6】
Szmuszkovicz, J.; Kane, M.P.; von Voigtlander, P.F.; A new non-tricyclic antidepressant agent. Synthesis and activity of N-[trans-2-(dimethyamino)cyclopentyl]-N-(3,4-dichlorophenyl)propanamide and related compounds. J Med Chem 1981, 24, 10, 1230-36.
|
【7】
Owen, R.T.; Serradell, M.N.; Castaner, J.; U-48753 E. Drugs Fut 1984, 9, 11, 846.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(B) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
34274 |
(1R,5S)-6-oxabicyclo[3.1.0]hexane
|
|
C5H8O |
详情 |
详情
|
(II) |
19443 |
N-methylmethanamine; N,N-dimethylamine
|
124-40-3 |
C2H7N |
详情 | 详情
|
(III) |
34275 |
(1S,2S)-2-(dimethylamino)cyclopentanol
|
|
C7H15NO |
详情 |
详情
|
(IV) |
34276 |
N,N-dimethyl-N-((1S,2S)-2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]cyclopentyl)amine; (1S,2S)-N,N-dimethyl-2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]cyclopentanamine
|
|
C10H21NOS |
详情 |
详情
|
(V) |
23629 |
3,4-dichloroaniline
|
95-76-1 |
C6H5Cl2N |
详情 | 详情
|
(VI) |
34277 |
N-[(1S,2S)-2-(3,4-dichloroanilino)cyclopentyl]-N,N-dimethylamine; (1S,2S)-N(1)-(3,4-dichlorophenyl)-N(2),N(2)-dimethyl-1,2-cyclopentanediamine
|
|
C13H18Cl2N2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(III) By condensation of 2,4-dimethyl-1-(2-aminoethyl)pyrrolidine (I) with 1-naphtalenesulfonyl chloride (II) in refluxing benzene, followed by a treatment with fumaric acid (III) in absolute ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27352 |
2-(2,4-dimethyl-1-pyrrolidinyl)-1-ethanamine
|
|
C8H18N2 |
详情 |
详情
|
(II) |
18650 |
1-naphthalenesulfonyl chloride
|
85-46-1 |
C10H7ClO2S |
详情 | 详情
|
(III) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(A) The reaction of 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (I) with methylamine by means of TiCl4 in refluxing benzene gives 7-chloro-5-(2-fluorophenyl)-2-methylamino-3H-1,4-benzodiazepine (II), which by reaction with NaNO2 in acetic acid is converted into its N-nitroso derivative (III). The treatment of (III) with nitromethane and potassium tert-butoxide in DMF affords 7-chloro-5-(2-fluorophenyl)-2-nitromethylene-2H-1,4-benzodiazepine (IV), which is reduced with H2 over Raney-Ni in THF affording the 2-aminomethyl derivative (V).The acetylation of (V) with acetic anhydride in CH2Cl2 gives the acetamide (VI), which is cyclized with polyphosphoric acid at 150 C yielding 8-chloro-3a,4-dihydro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine (VII). The deshydrogenation of (VII) with MnO2 in refluxing toluene affords 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine (VIII), which is finally treated with maleic acid (A) in hot ethanol.
【1】
Fryer, R.I.; Walser, A.; Benzo or heterocyclic fused imidazodiazepines and pharmaceutical compositions containing them. BE 0833248; DE 2540522; FR 2303016; GB 1527131; JP 51125099 .
|
【2】
Dhaon, M.K. (Abbott Laboratories Inc.); Process for the preparation of midazolam. WO 0170744 .
|
【3】
Thorpe, P.; Castaner, J.; Midazolam Maleate. Drugs Fut 1978, 3, 11, 822.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
33355 |
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
2886-65-9 |
C15H10ClFN2O |
详情 | 详情
|
(II) |
33558 |
N-[7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-yl]-N-methylamine; 7-chloro-5-(2-fluorophenyl)-N-methyl-3H-1,4-benzodiazepin-2-amine
|
|
C16H13ClFN3 |
详情 |
详情
|
(III) |
33559 |
N-[7-Chloro-5-(2-fluorophenyl)-3H-1,3-benzodiazepin-2-yl]-N-methyl-N-nitrosoamine
|
|
C16H12ClFN4O |
详情 |
详情
|
(IV) |
33560 |
7-chloro-5-(2-fluorophenyl)-2-[(Z)-nitromethylidene]-1,3-dihydro-2H-1,4-benzodiazepine
|
|
C16H11ClFN3O2 |
详情 |
详情
|
(V) |
33561 |
[7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methanamine; [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methylamine
|
|
C16H15ClFN3 |
详情 |
详情
|
(VI) |
33562 |
N-[[7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methyl]acetamide
|
|
C18H17ClFN3O |
详情 |
详情
|
(VII) |
33563 |
8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[1,5-a][1,4]benzodiazepine
|
|
C18H15ClFN3 |
详情 |
详情
|
(VIII) |
33564 |
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
|
59467-70-8 |
C18H13ClFN3 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(VI) The condensation of 3-hydroxy-1-methylpyrrolidine (I) with 2-chloronicotinic acid (II) by means of NaH in DMSO gives sodium 2-(1-methylpyrrolidin-3-yloxy)pyridine-3-carboxylate (III), which is then cyclized by a treatment with dry HCl in chloroform followed by a reaction with triphenylphosphine and CCl4 yielding finally 2-(2-chloroethyl)-4-methyl-3,4-dihydropyrido[3,2-f]-1,4-oxazepin-5(2H)-one (IV). The reaction of (IV) with P2S5 and K2S in refluxing toluene affords the corresponding thione (V), which is finally treated with 40% aqueous dimethylamine in ethanol at 100 C in a pressure vessel, and with fumaric acid (VI) in methanol.
【1】
Cale, A.D. Jr.; Franko, B.V.; Leonard, C.A. (A.H. Robins Co. Inc.); Fused aromatic oxazepinones and sulphur analogues thereof and their preparation and use in counteracting histamine. EP 0107930; ES 8607956; ES 8802574; US 4592866; US 4604388 .
|
【2】
Pento, J.T.; Castaner, R.M.; Serradell, M.N.; Castaner, J.; AHR-11325. Drugs Fut 1987, 12, 10, 924.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
28823 |
1-methyl-3-pyrrolidinol
|
13220-33-2 |
C5H11NO |
详情 | 详情
|
(II) |
28824 |
2-Chloropyridine-3-carboxylic acid; 2-Chloronicotinic acid
|
2942-59-8 |
C6H4ClNO2 |
详情 | 详情
|
(III) |
28825 |
sodium 2-[(1-methyl-3-pyrrolidinyl)oxy]nicotinate
|
|
C11H13N2NaO3 |
详情 |
详情
|
(IV) |
28826 |
2-(2-chloroethyl)-4-methyl-3,4-dihydropyrido[3,2-f][1,4]oxazepin-5(2H)-one
|
|
C11H13ClN2O2 |
详情 |
详情
|
(V) |
28827 |
2-(2-chloroethyl)-4-methyl-3,4-dihydropyrido[3,2-f][1,4]oxazepine-5(2H)-thione
|
|
C11H13ClN2OS |
详情 |
详情
|
(VI) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(A) The condensation of (IX) with alanine benzyl ester (X) with sodium cyanoboohydride as before gives N-[1-(ethoxycarbonyl)-3-phenylpropyl]alanine benzyl ester (XI), which is submitted to fractional crystallization with maleic acid yielding N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanine benzyl ester (XII), which is debenzylated by hydrogenation with H2 over Pd/C in ethanol yielding the free acid (XIII). Finally, this compound is condensed with spirane (IV) through the N-hydroxysuccinimide ester, in the usual way.
【1】
Smith, E.M.; Neustadt, B.R.; Gold, E.H. (Schering Corp.); 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. JP 1989163197; US 4470972 .
|
【2】
Prous, J.; Castaner, J.; Spirapril. Drugs Fut 1987, 12, 9, 860.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(IV) |
27316 |
methyl (8S)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate
|
|
C8H13NO2S2 |
详情 |
详情
|
(IX) |
20896 |
Ethyl 2-oxo-4-phenylbutanoate; 2-Oxo-4-phenylbutyric acid ethyl ester
|
64920-29-2 |
C12H14O3 |
详情 | 详情
|
(X) |
10143 |
benzyl (2S)-2-aminopropanoate
|
|
C10H13NO2 |
详情 |
详情
|
(XI) |
27321 |
ethyl 2-[[(1S)-2-(benzyloxy)-1-methyl-2-oxoethyl]amino]-4-phenylbutanoate
|
|
C22H27NO4 |
详情 |
详情
|
(XII) |
15665 |
ethyl (2S)-2-[[(1S)-2-(benzyloxy)-1-methyl-2-oxoethyl]amino]-4-phenylbutanoate
|
|
C22H27NO4 |
详情 |
详情
|
(XIII) |
11360 |
(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propionic acid; (S)-N-(1-Ethoxycarbonyl-3-phenylpropyl)-(S)-alanine
|
82717-96-2 |
C15H21NO4 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) The synthesis of [14 C]-EST has been described ac cording to the following procedure:
The oxidation of fumaric acid (I) with H2O2 gives trans-epoxysuccinic acid (II), which is submitted to optical resolution by means of its salt with L-arginine. The L-trans isomer (III) is esterified with ethanol and H2SO4 to the corresponding diethyl ester (IV), which is hydrolyzed selectively with KOH, affording the monoethyl ester (V). Finally, this monoester 5 condensed with N-isoamyl-L-leucinamide (VI).
【1】
Fukushima, K.; et al.; In vivo actions of EST (reort 1) - Absorption and excretion of 14C-EST. Kiso To Rinsho 1986, 20, 4, 319.
|
【2】
Castaner, J.; Prous, J.; EST. Drugs Fut 1986, 11, 11, 927.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(II) |
24349 |
2,3-oxiranedicarboxylic acid; Oxirane-2,3-dicarboxylic acid; Epoxysuccinic acid
|
|
C4H4O5 |
详情 |
详情
|
(III) |
24350 |
(2S,3S)-2,3-oxiranedicarboxylic acid
|
|
C4H4O5 |
详情 |
详情
|
(IV) |
24351 |
diethyl (2S,3S)-2,3-oxiranedicarboxylate
|
74243-85-9 |
C8H12O5 |
详情 | 详情
|
(V) |
24344 |
(2S,3S)-3-(ethoxycarbonyl)-2-oxiranecarboxylic acid
|
|
C6H8O5 |
详情 |
详情
|
(VI) |
24347 |
2-amino-N-isopentyl-4-methylpentanamide
|
|
C11H24N2O |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(A) The bromination of 4 benzyloxy-3-nitroacetophenone (I) with Br2 in CHCl3 gives 4-benzyloxy-3-nitro-alpha-bromoacetophenone (II), which is then condensed with N-benzyl-N-(1-methyl-2-(p-methoxyphenyl)ethyl]-amine (III) in butanone at 80 C yielding 4-benzyloxy-3-nitro-alpha-[N-benzyl-N-[1-methyl-2-(p-methoxyphenyl)ethyl]amino]acetophenone (IV). The reduction of the carbonyl group of (IV) with NaBH4 in ethanol affords the corresponding nitro alcohol (V), which is reduced again with Fe and HCl in ethanol - water to the amino alcohol (VI). The formylation of (VI) with formic acid in acetic anhydride gives 4-benzyloxy-3-formyl-amino-alpha-[N-benzyl-N-[1-methyl-2-(p-methoxyphenyl)ethyl]aminomethyl]benzyl alcohol (VII), which is finally debenzylated with H2 over Pd/C in ethanol and treated with fumaric acid (A).
【1】
Murakami, M.; et al.; alpha-Aminomethylbenzylalkoholderivative. DE 2305092; DE 2366625 .
|
【2】
Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
20627 |
1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanone
|
|
C15H13NO4 |
详情 |
详情
|
(II) |
32763 |
1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone
|
|
C15H12BrNO4 |
详情 |
详情
|
(III) |
33904 |
(2S)-N-benzyl-1-(4-methoxyphenyl)-2-propanamine; N-benzyl-N-[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amine
|
|
C17H21NO |
详情 |
详情
|
(IV) |
33900 |
2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanone
|
|
C32H32N2O5 |
详情 |
详情
|
(V) |
33901 |
(1R)-2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-[4-(benzyloxy)-3-nitrophenyl]-1-ethanol
|
|
C32H34N2O5 |
详情 |
详情
|
(VI) |
33902 |
(1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-ethanol
|
|
C32H36N2O3 |
详情 |
详情
|
(VII) |
33903 |
5-((1R)-2-[benzyl[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide
|
|
C33H36N2O4 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(A) By reduction of a mixture of 1-(3-formylamino-4-hydroxyphenyl)-2-aminoethanol (VIII) and 1-(4-methoxyphenyl)-2-propanone (IX) with H2 over Pt in ethanol, followed by a treatment with fumaric acid (A).
【1】
Tanoury GJ, Hett R,Kessler D,et aL 2002. Taking advantage of polymorphism to effect an impurity removalt: development of a thermodynamic crystal form of (R,R)-fonnoterol tartnte. Org Proc Res Dev,6
(6).855~862 |
【1】
Murase, K.; et al.; JP 7512040 .
|
【2】
Castaner, J.; Weetman, D.F.; BD 40A. Drugs Fut 1977, 2, 10, 639.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
66381 |
(1R,2S)-1-Amino-2-indanol |
7480-35-5 |
C9H11NO |
详情 | 详情
|
(II) |
32764 |
(3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3,2]oxazaborole
|
|
C9H10BNO |
详情 |
详情
|
(III) |
32765 |
(1R)-1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanol
|
188690-82-6 |
C15H14BrNO4 |
详情 | 详情
|
(IV) |
32766 |
(1R)-1-[3-amino-4-(benzyloxy)phenyl]-2-bromo-1-ethanol
|
|
C15H16BrNO2 |
详情 |
详情
|
(V) |
32767 |
2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]phenylformamide
|
|
C16H16BrNO3 |
详情 |
详情
|
(VI) |
32738 |
tert-butyl (2S,3S)-2-[(2-[[2-([[(1S,2S)-1-(tert-butoxycarbonyl)-2-methylbutyl]amino]carbonyl)phenyl]disulfanyl]benzoyl)amino]-3-methylpentanoate
|
|
C34H48N2O6S2 |
详情 |
详情
|
(VII) |
32769 |
5-((1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl)-2-(benzyloxy)phenylformamide
|
|
C33H36N2O4 |
详情 |
详情
|
(VIII) |
33905 |
5-[(1R)-2-amino-1-hydroxyethyl]-2-hydroxyphenylformamide
|
|
C9H12N2O3 |
详情 |
详情
|
(VIII) |
66382 |
N-[2-Hydroxy-5-[1(R)-hydroxy-2-[2-(4-methoxyphenyl)-1(R)-methylethylamino]ethyl]phenyl]formamide |
67346-49-0 |
C19H24N2O4 |
详情 | 详情
|
(IX) |
10038 |
4-Methoxyphenylacetone; 1-(4-Methoxyphenyl)acetone
|
122-84-9 |
C10H12O2 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
The racemic compound RP 58866 was synthesized as follows:
The ethyl ester of (2,3-dihydro-4H-1-benzopyran-4-ylidene)acetic acid (II) is prepared by carrying out the Wittig-Horner reaction on commercially available chromanone (I), followed by catalytic hydrogenation over 10% Pd on carbon to yield the ethyl ester of 3,4-dihydro-2H-1-benzopyran-4-acetic acid (III). Reduction of this ester with lithium aluminum hydride gives the alcohol (IV), which is converted into the corresponding bromide (V) (1, 3) by reaction with N,N'-carbonyldiimidazole and an excess of allyl bromide. Subsequent condensation of (V) with 4-(3,4-dimethoxyphenyl)piperidine (VI) by refluxing in 2-butanone, followed by the addition of (E)-2-butenedioic acid (fumaric acid), yields the salt (RS)-1-[2-(3,4-dihydro-2H-1-benzopyran-4-yl)ethyl]-4-(3,4-dimethoxyphenyl)piperidine (E)-2-butenedioate (1:1) (VII).
【1】
Hardy, J.-C.; Renault, C. (Aventis SA); Novel benzopyran derivs., their preparation and medicines containing them. (Rhône-Poulenc Santé). AU 8819713; EP 0300908; FR 2618437; JP 1989040476; US 4977166 . |
【2】
Barreau, M.; Hardy, J.-C.; Martin, J.-P.; Renault, C. (Aventis SA); Benzopyran derivs., their preparation and pharmaceutical compsns. Containing them. (Rhône-Poulenc Santé). AU 9048584; EP 0379441; FR 2642069; JP 1990233675; US 5025013 . |
【3】
Barreau, M.; Hardy, J.-C.; Renault, C. (Aventis SA); Novel benzopyran derivs., their preparation and pharmaceutical compsns. containing them. (Rhône-Poulenc Santé). AU 9048583; EP 0379440; FR 2642068; JP 1990229188; US 4994470 . |
【4】
Mestre, M.; Cavero, I.; Hardy, J.-C.; Barreau, M.; Terikalant Fumarate. Drugs Fut 1992, 17, 12, 1097.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10019 |
Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate
|
867-13-0 |
C8H17O5P |
详情 | 详情
|
|
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(I) |
14461 |
2,3-Dihydro-4H-chromen-4-one; 4-Chromanone
|
491-37-2 |
C9H8O2 |
详情 | 详情
|
(II) |
14462 |
ethyl 2-(2,3-dihydro-4H-chromen-4-ylidene)acetate
|
|
C13H14O3 |
详情 |
详情
|
(III) |
14463 |
ethyl 2-(3,4-dihydro-2H-chromen-4-yl)acetate
|
|
C13H16O3 |
详情 |
详情
|
(IV) |
14464 |
2-(3,4-dihydro-2H-chromen-4-yl)-1-ethanol
|
|
C11H14O2 |
详情 |
详情
|
(V) |
14465 |
4-(2-bromoethyl)chromane
|
|
C11H13BrO |
详情 |
详情
|
(VI) |
14466 |
4-(3,4-dimethoxyphenyl)piperidine; 2-methoxy-4-(4-piperidinyl)phenyl methyl ether
|
|
C13H19NO2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
Terikalant, the (S)-enantiomer of RP 58866, was synthesized as follows:
After hydrolysis of the ethyl ester (III) with NaOH in refluxing methanol, the corresponding acid (VIII) is converted into the acid chloride by refluxing in thionyl chloride. After removal of excess thionyl chloride, the residue is distilled off under reduced pressure to yield the carboxylic acid chloride (IX). Subsequent reaction of (IX) with (R)-(-)-phenylglycinol yields a mixture of the (SR)-3,4-dihydro-N-(2-hydroxy-1-phenethyl)-2H-1-benzopyran-4-acetamide (Xa) [m.p. 143 C; alpha(D) -43 (c 1.5, EtOH)] and (RR)-3,4-dihydro-N-(2-hydroxy-1-phenethyl)-2H-1-benzopyran-4-acetamide (Xb) [m.p. 140 C; alpha(D) -6.5 (c 1.5, EtOH)] diastereoisomers, which are separated by silica gel column chromatography using methylene chloride/ethanol (95/5) as eluent and subsequently hydrolyzed to give the two pure enatiomeric carboxylic acids: (S)-(XIa) [alpha(D) -18.5 (c 1.1, EtOH)], e.e. 99.3% determined by analytical HPLC on the amide derived from (R)-(-)-phenylglycinol, and (R)-(XIb) [alpha(D) +17.4 (c 1, EtOH)]; m.p. 77-8 C. Reduction of (XIa) with lithium aluminum hydride in tetrahydrofuran gives the alcohol (XII), which is converted into the bromide (XIII) and, subsequently, to (S)-1-[2-(3,4-dihydro-2H-1-benzopyran-4-yl)ethyl]-4-(3,4-dimethoxyphenyl)piperidine (E)-2-butenedioate (1:1) , analogously with the racemic compound described in scheme 16777901a. RP 62719 is recrystallized from isopropanol and the absolute configuration is obtained through single crystal x-ray analysis of the bromhydrate. The pure (R)-isomer, RP 62718, is obtained according to the same reaction scheme as that described for (XIa), but starting with (XIb).
【1】
Cavero, I.; Renault, C.; Hardy, J.-C.; Barreau, M.; Bouquerel, J.; Mestre, M.; Synthesis and biological evaluation of RP 62719, the active enantiomer of RP 58866, a pure class III antiarrhythmic agent. 11th Int Symp Med Chem (Sept 2-7, Jerusalem) 1990, 37. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14376 |
(2R)-2-amino-2-phenyl-1-ethanol; (R)-(-)-2-phenylglycinol; (R)-2-amino-2-phenyl-1-ethanol
|
56613-80-0 |
C8H11NO |
详情 | 详情
|
|
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
(Xb) |
14469 |
2-[(4S)-3,4-dihydro-2H-chromen-4-yl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide
|
|
C19H21NO3 |
详情 |
详情
|
(Xa) |
14470 |
2-[(4R)-3,4-dihydro-2H-chromen-4-yl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide
|
|
C19H21NO3 |
详情 |
详情
|
(XIb) |
14471 |
2-[(4S)-3,4-dihydro-2H-chromen-4-yl]acetic acid
|
|
C11H12O3 |
详情 |
详情
|
(XIa) |
14472 |
2-[(4R)-3,4-dihydro-2H-chromen-4-yl]acetic acid
|
|
C11H12O3 |
详情 |
详情
|
(III) |
14463 |
ethyl 2-(3,4-dihydro-2H-chromen-4-yl)acetate
|
|
C13H16O3 |
详情 |
详情
|
(VI) |
14466 |
4-(3,4-dimethoxyphenyl)piperidine; 2-methoxy-4-(4-piperidinyl)phenyl methyl ether
|
|
C13H19NO2 |
详情 |
详情
|
(VIII) |
14467 |
2-(3,4-dihydro-2H-chromen-4-yl)acetic acid
|
|
C11H12O3 |
详情 |
详情
|
(IX) |
14468 |
2-(3,4-dihydro-2H-chromen-4-yl)acetyl chloride
|
|
C11H11ClO2 |
详情 |
详情
|
(XII) |
14473 |
2-[(4S)-3,4-dihydro-2H-chromen-4-yl]-1-ethanol
|
|
C11H14O2 |
详情 |
详情
|
(XIII) |
14474 |
(4R)-4-(2-bromoethyl)-3,4-dihydro-2H-chromene
|
|
C11H13BrO |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(IX) N-(2,2-Diphenylacetyl)piperazine (IV) was prepared by acylation of N-formylpiperazine (II) with 2,2-diphenylacetyl chloride (I), followed by acid-promoted formyl deprotection of the resulting amide (III). Condensation of 5-hydroxyquinoline (VI) with epichlorohydrin (V) in the presence of potassium tert-butoxide in DMF at 90 C provided 5-(2,3-epoxypropoxy)quinoline (VII), which was subsequently coupled with acylpiperazine (IV) in boiling isopropanol to yield (VIII). This was finally treated with fumaric acid (IX) in MeOH to furnish the title sesquifumarate salt.
【1】
Suzuki, T.; et al.; Structure-activity relationship of newly synthesiz. J Med Chem 1997, 40, 13, 2047.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23800 |
Diphenylacetyl chloride; 2,2-diphenylacetyl chloride
|
1871-76-7 |
C14H11ClO |
详情 | 详情
|
(II) |
23801 |
1-piperazinecarbaldehyde; N-Formylpiperazine
|
7755-92-2 |
C5H10N2O |
详情 | 详情
|
(III) |
23802 |
4-(2,2-diphenylacetyl)-1-piperazinecarbaldehyde
|
|
C19H20N2O2 |
详情 |
详情
|
(IV) |
23803 |
2,2-diphenyl-1-(1-piperazinyl)-1-ethanone
|
|
C18H20N2O |
详情 |
详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(VI) |
23805 |
5-quinolinol
|
578-67-6 |
C9H7NO |
详情 | 详情
|
(VII) |
23806 |
5-(2-oxiranylmethoxy)quinoline; 2-oxiranylmethyl 5-quinolinyl ether
|
|
C12H11NO2 |
详情 |
详情
|
(VIII) |
23807 |
1-[4-[2-hydroxy-3-(5-quinolinyloxy)propyl]-1-piperazinyl]-2,2-diphenyl-1-ethanone
|
|
C30H31N3O3 |
详情 |
详情
|
(IX) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(IX) Pyridazinone (I) was converted to 3,4,5-trichloropyridazine (VIII) on treatment with POCl3. Nucleophylic substitution in (II) with 3-aminopropanol (III) gave, after crystallization, the desired isomer (IV). Hydrolysis of the 3-chloro group of (IV) was carried out with AcOH and AcONa, resulting in the N,O-diacetyl derivative (V). Subsequent reaction of (V) with aqueous HBr provided bromide (VI), which was then treated with N-methyl homoveratrylamine (VII) to furnish the target compound (VIII). This compound was finally isolated as the fumarate salt on treatment with fumaric acid in EtOH (1).
【1】
Kotay-Nagy, P.; et al.; A new synthesis of EGIS-7229, a potent antiarrhythmic drug-candidate. 15th European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (Sept 6 1998, Edinburgh) 1998, Abst P.151.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24570 |
4,5-dichloro-3(2H)-pyridazinone
|
|
C4H2Cl2N2O |
详情 |
详情
|
(II) |
27529 |
3,4,5-trichloropyridazine
|
14161-11-6 |
C4HCl3N2 |
详情 | 详情
|
(III) |
18522 |
3-amino-1-propanol
|
156-87-6 |
C3H9NO |
详情 | 详情
|
(IV) |
27530 |
3-[(3,5-dichloro-4-pyridazinyl)amino]-1-propanol
|
|
C7H9Cl2N3O |
详情 |
详情
|
(V) |
27531 |
3-[acetyl(5-chloro-3-oxo-2,3-dihydro-4-pyridazinyl)amino]propyl acetate
|
|
C11H14ClN3O4 |
详情 |
详情
|
(VI) |
27532 |
4-[(3-bromopropyl)amino]-5-chloro-3(2H)-pyridazinone
|
|
C7H9BrClN3O |
详情 |
详情
|
(VII) |
18938 |
2-(3,4-dimethoxyphenyl)-N-methyl-1-ethanamine; N-(3,4-dimethoxyphenethyl)-N-methylamine
|
3490-06-0 |
C11H17NO2 |
详情 | 详情
|
(VIII) |
27533 |
5-chloro-4-([3-[(3,4-dimethoxyphenethyl)(methyl)amino]propyl]amino)-3(2H)-pyridazinone
|
|
C18H25ClN4O3 |
详情 |
详情
|
(IX) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(XVI) Activation of butyric acid derivative (I) with isobutyl chloroformate (II) by means of Et3N in THF, followed by coupling with ethylamine (III) in THF in the presence of Et3N, yields butyramide derivative (IV). Reduction of (IV) by means of (-)-B-chlorodiisopinocampheylborane (Ipc2BCl) in THF, followed by reaction with diethanolamine (A), affords hydroxy derivative (V), whose carbonyl group is removed by means of sodium bis(2-methoxyethoxy)aluminum hydride (Red-Al) in toluene/THF, followed by treatment with H2SO4 to provide compound (VI) .
Separately, the synthesis of intermediate (XIV) is performed as follows: condensation of pentamethylene chlorohydrin (VII) with 3,4-dihydro-2H-pyran (VIII) by means of p-toluenesulfonic acid in Et2O furnishes 5-chloropentyl-2-tetrahydropyranyl ether (IX), which is then subjected to reaction with acetone (X) in THF by means of Mg in the presence of 1,2-dibromoethane (B) to provide tetrahydropyranyl ether (XI). Conversion of hydroxy derivative (XI) into the corresponding fluoro derivative (XII) is performed by reaction with diethylaminosulfur trifluoride (DAST) in CH2Cl2, and posterior reaction of (XII) with pyridinium p-toluenesulfonate in EtOH furnishes 6-fluoro-6-methyl-1-heptanol (XIII). Finally, intermediate (XIV) is obtained by reaction of (XIII) with NBS and PPh3 in benzene.
Condensation of secondary amine (VI) with intermediate (XIV) by means of NaHCO3 in refluxing acetonitrile provides methanesulfonamide (XV), which is finally converted into the target product by formation of the hemifumarate salt by treatment with fumaric acid (XVI) in acetone.
【1】
Hester, J.B.; Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: Synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential. J Med Chem 2001, 44, 7, 1099. |
【2】
Hester, J.B. Jr.; Gibson, J.K. (Pharmacia Corp.); Antiarrhythmic (S)-enantiomers of methanesulfonamides. EP 0802900; JP 1999500418; WO 9621643 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(A) |
24273 |
2-[(2-hydroxyethyl)amino]-1-ethanol
|
111-42-2 |
C4H11NO2 |
详情 | 详情
|
(I) |
14625 |
4-[4-[(methylsulfonyl)amino]phenyl]-4-oxobutyric acid
|
|
C11H13NO5S |
详情 |
详情
|
(II) |
14932 |
isobutyryl chloride; 2-methylpropanoyl chloride
|
79-30-1 |
C4H7ClO |
详情 | 详情
|
(III) |
10928 |
Ethanamine
|
75-04-7 |
C2H7N |
详情 | 详情
|
(IV) |
48114 |
N-ethyl-4-[4-[(methylsulfonyl)amino]phenyl]-4-oxobutanamide
|
|
C13H18N2O4S |
详情 |
详情
|
(V) |
48115 |
(4S)-N-ethyl-4-hydroxy-4-[4-[(methylsulfonyl)amino]phenyl]butanamide
|
|
C13H20N2O4S |
详情 |
详情
|
(VI) |
48116 |
N-[4-[(1S)-4-(ethylamino)-1-hydroxybutyl]phenyl]methanesulfonamide
|
|
C13H22N2O3S |
详情 |
详情
|
(VII) |
48117 |
5-chloro-1-pentanol
|
|
C5H11ClO |
详情 |
详情
|
(VIII) |
13684 |
3,4-Dihydro-2H-pyran;2,3-Dihydro-4H-pyran; 5,6-Dihydro-4H-pyran;Dihydropyran |
110-87-2 |
C5H8O |
详情 | 详情
|
(IX) |
48118 |
2-[(5-chloropentyl)oxy]tetrahydro-2H-pyran; 5-chloropentyl tetrahydro-2H-pyran-2-yl ether
|
|
C10H19ClO2 |
详情 |
详情
|
(X) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(XI) |
48119 |
2-methyl-6-(tetrahydro-2H-pyran-2-yloxy)-2-hexanol
|
|
C12H24O3 |
详情 |
详情
|
(XII) |
48120 |
5-fluoro-5-methylhexyl tetrahydro-2H-pyran-2-yl ether; 2-[(5-fluoro-5-methylhexyl)oxy]tetrahydro-2H-pyran
|
|
C12H23FO2 |
详情 |
详情
|
(XIII) |
48121 |
6-fluoro-6-methyl-1-heptanol
|
|
C8H17FO |
详情 |
详情
|
(XIV) |
48122 |
1-bromo-6-fluoro-6-methylheptane
|
|
C8H16BrF |
详情 |
详情
|
(XV) |
48123 |
N-(4-[(1S)-4-[ethyl(6-fluoro-6-methylheptyl)amino]-1-hydroxybutyl]phenyl)methanesulfonamide
|
|
C21H37FN2O3S |
详情 |
详情
|
(XVI) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(XIII) The protection of the NH2 group of L-serine (I) gives N-(benzyloxycarbonyl)-L-serine (II), which is converted into the N-methylamide (III). The reduction of the amide group of (III) affords the diaminopropanol (IV), which is N-protected to provide the Boc-protected compound (V). The mesylation of the OH group of (V) gives the mesylate (VI), which is treated with ethylamine to yield the triaminopropane (VII). Boc deprotection in (VII) with HCl affords intermediate (VIII), which is submitted to a reductive cyclization with glyoxal and BH3/TEA to provide the perhydro-1,4-diazepine (IX). Cbz deprotection in (IX) by hydrogenation with H2 over Pd/C gives the 1-ethyl-4-methylperhydro-1,4-diazepin-6(R)-amine (X), which is condensed with 5-bromo-2-methoxy-6-(methylamino)pyridine-3-carboxylic acid (XI) by means of ethyl chloroformate and TEA to yield the target amide (XII). Finally, this compound is treated with fumaric acid (XIII) in ethanol to afford the desired fumarate salt.
【1】
Hirokawa, Y.; et al.; Process development of the synthetic route to (R)-6-amino-1-ethyl-4-methylhexahydro-1,4-diazepine. Org Process Res Dev 2002, 6, 1, 28.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
51660 |
methyl (2S)-2-[[(benzyloxy)carbonyl]amino]-3-hydroxypropanoate
|
|
C12H15NO5 |
详情 |
详情
|
(III) |
53991 |
benzyl (1S)-1-(hydroxymethyl)-2-(methylamino)-2-oxoethylcarbamate
|
n/a |
C12H16N2O4 |
详情 | 详情
|
(IV) |
53992 |
benzyl (1R)-2-hydroxy-1-[(methylamino)methyl]ethylcarbamate
|
n/a |
C12H18N2O3 |
详情 | 详情
|
(V) |
53993 |
benzyl (1R)-2-[(tert-butoxycarbonyl)(methyl)amino]-1-(hydroxymethyl)ethylcarbamate
|
n/a |
C17H26N2O5 |
详情 | 详情
|
(VI) |
53994 |
(2R)-2-{[(benzyloxy)carbonyl]amino}-3-[(tert-butoxycarbonyl)(methyl)amino]propyl methanesulfonate
|
n/a |
C18H28N2O7S |
详情 | 详情
|
(VII) |
53995 |
benzyl (1S)-2-[(tert-butoxycarbonyl)(methyl)amino]-1-[(ethylamino)methyl]ethylcarbamate
|
n/a |
C19H31N3O4 |
详情 | 详情
|
(VIII) |
53996 |
benzyl (1R)-2-(ethylamino)-1-[(methylamino)methyl]ethylcarbamate
|
n/a |
C14H23N3O2 |
详情 | 详情
|
(IX) |
53997 |
benzyl (6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylcarbamate
|
n/a |
C16H25N3O2 |
详情 | 详情
|
(X) |
17802 |
(6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylamine; (6S)-1-ethyl-4-methyl-1,4-diazepan-6-amine
|
|
C8H19N3 |
详情 |
详情
|
(XI) |
17801 |
5-bromo-2-methoxy-6-(methylamino)nicotinic acid
|
|
C8H9BrN2O3 |
详情 |
详情
|
(XII) |
53998 |
5-bromo-N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-6-(methylamino)nicotinamide
|
n/a |
C16H26BrN5O2 |
详情 | 详情
|
(XIII) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(XVI) The protection of the NH2 group of L-serine (I) gives N-(benzyloxycarbonyl)-L-serine (II), which is converted into the N-methylamide (III). The reduction of the amide group of (III) affords the diaminopropanol (IV), which is N-protected to provide the Boc-protected compound (V). The mesylation of the OH group of (V) gives the mesylate (VI), which is treated with ethylamine to yield the triaminopropane (VII). The condensation of (VII) with ethyl bromoacetate (VIII) affords the aminoacetate (IX), which is selectively deprotected with HCl to provide the intermediate (X). The cyclization of (X) by means of NaOEt gives the perhydro-1,4-diazepin-2-one (XI), which is reduced with BH3/THF to yield the perhydro-1,4-diazepine (XII). Cbz deprotection in (XII) by hydrogenation with H2 over Pd/C gives the 1-ethyl-4-methylperhydro-1,4-diazepin-6(R)-amine (XIII), which is condensed with 5-bromo-2-methoxy-6-(methylamino)pyridine-3-carboxylic acid (XIV) by means of ethyl chloroformate and TEA to yield the target amide (XV). Finally, this compound is treated with fumaric acid (XVI) in ethanol to afford the desired fumarate salt.
【1】
Hirokawa, Y.; et al.; Process development of the synthetic route to (R)-6-amino-1-ethyl-4-methylhexahydro-1,4-diazepine. Org Process Res Dev 2002, 6, 1, 28.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
51660 |
methyl (2S)-2-[[(benzyloxy)carbonyl]amino]-3-hydroxypropanoate
|
|
C12H15NO5 |
详情 |
详情
|
(III) |
53991 |
benzyl (1S)-1-(hydroxymethyl)-2-(methylamino)-2-oxoethylcarbamate
|
n/a |
C12H16N2O4 |
详情 | 详情
|
(IV) |
53992 |
benzyl (1R)-2-hydroxy-1-[(methylamino)methyl]ethylcarbamate
|
n/a |
C12H18N2O3 |
详情 | 详情
|
(V) |
53993 |
benzyl (1R)-2-[(tert-butoxycarbonyl)(methyl)amino]-1-(hydroxymethyl)ethylcarbamate
|
n/a |
C17H26N2O5 |
详情 | 详情
|
(VI) |
53994 |
(2R)-2-{[(benzyloxy)carbonyl]amino}-3-[(tert-butoxycarbonyl)(methyl)amino]propyl methanesulfonate
|
n/a |
C18H28N2O7S |
详情 | 详情
|
(VII) |
53995 |
benzyl (1S)-2-[(tert-butoxycarbonyl)(methyl)amino]-1-[(ethylamino)methyl]ethylcarbamate
|
n/a |
C19H31N3O4 |
详情 | 详情
|
(VIII) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(IX) |
53999 |
ethyl 2-[{(2S)-2-{[(benzyloxy)carbonyl]amino}-3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(ethyl)amino]acetate
|
n/a |
C23H37N3O6 |
详情 | 详情
|
(X) |
54000 |
ethyl 2-[[(2R)-2-{[(benzyloxy)carbonyl]amino}-3-(methylamino)propyl](ethyl)amino]acetate
|
n/a |
C18H29N3O4 |
详情 | 详情
|
(XI) |
54001 |
benzyl (6S)-4-ethyl-1-methyl-2-oxo-1,4-diazepan-6-ylcarbamate
|
n/a |
C16H23N3O3 |
详情 | 详情
|
(XII) |
53997 |
benzyl (6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylcarbamate
|
n/a |
C16H25N3O2 |
详情 | 详情
|
(XIII) |
17802 |
(6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylamine; (6S)-1-ethyl-4-methyl-1,4-diazepan-6-amine
|
|
C8H19N3 |
详情 |
详情
|
(XIV) |
17801 |
5-bromo-2-methoxy-6-(methylamino)nicotinic acid
|
|
C8H9BrN2O3 |
详情 |
详情
|
(XV) |
53998 |
5-bromo-N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-6-(methylamino)nicotinamide
|
n/a |
C16H26BrN5O2 |
详情 | 详情
|
(XVI) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(XII) The protection of the NH2 group of L-serine (I) with Ts-Cl and TEA gives N-tosyl-L-serine (II), which is converted into the N-methylamide (III). The cyclization of (III) by means of diisopropylazodicarboxylate (DIAD) yields the N-tosylaziridine (IV), which is treated with ethylamine (V) to afford the diaminopropionamide (VI). The reduction of the amide group of (VI) with LiAlH4 provides the triaminopropane (VII), which is submitted to a reductive cyclization with glyoxal and BH3/TEA to give the perhydro-1,4-diazepine (VIII). Ts deprotection in (VIII) by means of HBr affords the 1-ethyl-4-methylperhydro-1,4-diazepin-6(R)-amine (IX), which is condensed with 5-bromo-2-methoxy-6-(methylamino)pyridine-3-carboxylic acid (X) by means of ethyl chloroformate and TEA to yield the target amide (XI). Finally, this compound is treated with fumaric acid (XII) in ethanol to afford the desired fumarate salt.
【1】
Hirokawa, Y.; et al.; Process development of the synthetic route to (R)-6-amino-1-ethyl-4-methylhexahydro-1,4-diazepine. Org Process Res Dev 2002, 6, 1, 28.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
54002 |
methyl (2S)-3-hydroxy-2-{[(4-methylphenyl)sulfonyl]amino}propanoate
|
n/a |
C11H15NO5S |
详情 | 详情
|
(III) |
54003 |
(2S)-3-hydroxy-N-methyl-2-{[(4-methylphenyl)sulfonyl]amino}propanamide
|
n/a |
C11H16N2O4S |
详情 | 详情
|
(IV) |
54004 |
(2S)-N-methyl-1-[(4-methylphenyl)sulfonyl]-2-aziridinecarboxamide
|
n/a |
C11H14N2O3S |
详情 | 详情
|
(V) |
10928 |
Ethanamine
|
75-04-7 |
C2H7N |
详情 | 详情
|
(VI) |
54005 |
(2S)-3-(ethylamino)-N-methyl-2-{[(4-methylphenyl)sulfonyl]amino}propanamide
|
n/a |
C13H21N3O3S |
详情 | 详情
|
(VII) |
54006 |
N-{(1R)-2-(ethylamino)-1-[(methylamino)methyl]ethyl}-4-methylbenzenesulfonamide
|
n/a |
C13H23N3O2S |
详情 | 详情
|
(VIII) |
54007 |
N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-4-methylbenzenesulfonamide
|
n/a |
C15H25N3O2S |
详情 | 详情
|
(IX) |
17802 |
(6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylamine; (6S)-1-ethyl-4-methyl-1,4-diazepan-6-amine
|
|
C8H19N3 |
详情 |
详情
|
(X) |
17801 |
5-bromo-2-methoxy-6-(methylamino)nicotinic acid
|
|
C8H9BrN2O3 |
详情 |
详情
|
(XI) |
53998 |
5-bromo-N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-6-(methylamino)nicotinamide
|
n/a |
C16H26BrN5O2 |
详情 | 详情
|
(XII) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(XX) The reaction of N-methyl-N'-(3-methylbenzyl)ethylene-1,2-diamine (VIII) with (Boc)2O in chloroform gives N-(tert-butoxycarbonyl)-N-methyl-N'-(3-methylbenzyl)ethylene-1,2-diamine (IX), which is condensed with the chiral aziridine (X) by heating at 80 C to yield the diaminobutyric ester (XI). Selective elimination of the Boc protecting group of (XI) with HCl in methanol affords the methylamino intermediate (XII), which is treated with NaOH in ethanol/water to provide the carboxylic acid (XIII). The cyclization of (XIII) by means of DEC gives the perhydro-1,4-diazepin-5-one derivative (XIV), which is debenzylated by means of 1-chloroethyl chloroformate to yield the 6(S)-(benzyloxycarbonylamino)-4-methylperhydro-1,4-diazepin-5-one (XV). The reductive alkylation of (XV) with acetaldehyde, NaBH4 and TEA in methanol affords the 1-ethyl derivative (XVI), which is deprotected by means of conc. HBr to provide 6(S)-amino-1-ethyl-4-methylperhydro-1,4-diazepin-5-one (XVII). The reduction of (XVII) with BH3/THF gives 1-ethyl-4-methylperhydro-1,4-diazepin-6(R)-amine (XVIII), which is condensed with 5-bromo-2-methoxy-6-(methylamino)pyridine-3-carboxylic acid (VII) by means of ethyl chloroformate and TEA to yield the target amide (XIX). Finally, this compound is treated with fumaric acid (XX) in ethanol to afford the desired fumarate salt.
【1】
Kato, S.; Hirokawa, Y.; Morie, T.; Harada, H.; Yoshida, N. (Dainippon Pharmaceutical Co., Ltd.); (R)-5-Bromo-N-(1-ethyl-4-methylhexahydro-1H-1, 4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal compsn. containing the same. EP 0855397; JP 1997100276; JP 1997118669; US 5945415; WO 9705129 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
17801 |
5-bromo-2-methoxy-6-(methylamino)nicotinic acid
|
|
C8H9BrN2O3 |
详情 |
详情
|
(VIII) |
54009 |
N~1~-methyl-N~2~-(3-methylbenzyl)-1,2-ethanediamine; N-methyl-N-{2-[(3-methylbenzyl)amino]ethyl}amine
|
n/a |
C11H18N2 |
详情 | 详情
|
(IX) |
54010 |
tert-butyl methyl{2-[(3-methylbenzyl)amino]ethyl}carbamate
|
n/a |
C16H26N2O2 |
详情 | 详情
|
(X) |
54011 |
1-benzyl 2-methyl (2S)-1,2-aziridinedicarboxylate
|
n/a |
C12H13NO4 |
详情 | 详情
|
(XI) |
54012 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-4-[{2-[(tert-butoxycarbonyl)(methyl)amino]ethyl}(3-methylbenzyl)amino]butanoate
|
n/a |
C29H41N3O6 |
详情 | 详情
|
(XII) |
54013 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-4-[[2-(methylamino)ethyl](3-methylbenzyl)amino]butanoate
|
n/a |
C24H33N3O4 |
详情 | 详情
|
(XIII) |
54014 |
(2S)-2-{[(benzyloxy)carbonyl]amino}-4-[[2-(methylamino)ethyl](3-methylbenzyl)amino]butanoic acid
|
n/a |
C23H31N3O4 |
详情 | 详情
|
(XIV) |
54015 |
benzyl (6S)-4-methyl-1-(3-methylbenzyl)-5-oxo-1,4-diazepan-6-ylcarbamate
|
n/a |
C22H27N3O3 |
详情 | 详情
|
(XV) |
54016 |
benzyl (6S)-1-methyl-7-oxo-1,4-diazepan-6-ylcarbamate
|
n/a |
C14H19N3O3 |
详情 | 详情
|
(XVI) |
54017 |
benzyl (6S)-1-ethyl-4-methyl-5-oxo-1,4-diazepan-6-ylcarbamate
|
n/a |
C16H23N3O3 |
详情 | 详情
|
(XVII) |
54018 |
(6S)-6-amino-1-ethyl-4-methyl-1,4-diazepan-5-one
|
n/a |
C8H17N3O |
详情 | 详情
|
(XVIII) |
17802 |
(6S)-1-ethyl-4-methyl-1,4-diazepan-6-ylamine; (6S)-1-ethyl-4-methyl-1,4-diazepan-6-amine
|
|
C8H19N3 |
详情 |
详情
|
(XIX) |
53998 |
5-bromo-N-[(6S)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-6-(methylamino)nicotinamide
|
n/a |
C16H26BrN5O2 |
详情 | 详情
|
(XX) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线24
该中间体在本合成路线中的序号:
(IX) The hydrolysis of 4-acetamido-2-methyl-2,3-dihydrobenzofuran-7-carboxylic acid methyl ester (I) with NaOH gives the corresponding free acid (II), which is esterified with benzyl alcohol and carbonyldiimidazole (CDI) to the benzyl ester (III). Optical resolution of (III) by chiral HPLC yielded the 2(S)-isomer (IV), which is chlorinated with N-chlorosuccinomide (NCl) affords the 5-chloro derivative (V). The treatment of (V) with NaOH provides 4-amino-5-chloro-2(S)-methyl-2,3-dihydrobenzofuran-7-carboxylic acid (VI), which is condensed with the ethylamino derivative (VII) by means of CDI to give the amide (VIII). Finally, this compound is salified with fumaric acid (IX).
【1】
Kakigami, T.; et al.; Serotonin 5-HT4 receptor agonistic activity of the optical isomers of (±)-4-amino-N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-5-chloro-2,3-dihydro-2-methylbenzo[b]furan-7-carboxamide. Chem Pharm Bull 1998, 46, 6, 1039. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27629 |
methyl 4-(acetamido)-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylate
|
|
C13H15NO4 |
详情 |
详情
|
(II) |
27630 |
4-(acetamido)-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylic acid
|
|
C12H13NO4 |
详情 |
详情
|
(III) |
27631 |
benzyl 4-(acetamido)-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylate
|
|
C19H19NO4 |
详情 |
详情
|
(IV) |
27632 |
benzyl (2S)-4-(acetamido)-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylate
|
|
C19H19NO4 |
详情 |
详情
|
(V) |
27633 |
benzyl (2S)-4-(acetamido)-5-chloro-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylate
|
|
C19H18ClNO4 |
详情 |
详情
|
(VI) |
27634 |
(2S)-4-amino-5-chloro-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylic acid
|
|
C10H10ClNO3 |
详情 |
详情
|
(VII) |
19916 |
2-tetrahydro-1H-pyrrolizin-7(5H)-ylethylamine; 2-tetrahydro-1H-pyrrolizin-7(5H)-yl-1-ethanamine
|
|
C9H18N2 |
详情 |
详情
|
(VIII) |
27635 |
(2S)-4-amino-5-chloro-2-methyl-N-[2-tetrahydro-1H-pyrrolizin-7(5H)-ylethyl]-2,3-dihydro-1-benzofuran-7-carboxamide
|
|
C19H26ClN3O2 |
详情 |
详情
|
(IX) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(V) The optical resolution of 4-amino-5-chloro-2-methyl-2,3-dihydrobenzofuran-7-carboxylic acid (I) by means of brucine in methanol gives the (+)-isomer (II), which is then condensed with the ethylamino derivative (III) by means of carbonyldiimidazole in THF to afford the amide (IV). Finally, this compound is salified with fumaric acid (V) in ethanol.
【1】
Baba, Y.; Usui, T.; Iwata, N. (Sanwa Kagaku Kenkyusho Co., Ltd.); Benzo[b]furancarboxamide derivs., process for their preparation and their use as gastrointestinal mobility-enhancing agents. EP 0640602; JP 1995112985; US 5442077 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27636 |
4-amino-5-chloro-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylic acid
|
|
C10H10ClNO3 |
详情 |
详情
|
(II) |
27634 |
(2S)-4-amino-5-chloro-2-methyl-2,3-dihydro-1-benzofuran-7-carboxylic acid
|
|
C10H10ClNO3 |
详情 |
详情
|
(III) |
19916 |
2-tetrahydro-1H-pyrrolizin-7(5H)-ylethylamine; 2-tetrahydro-1H-pyrrolizin-7(5H)-yl-1-ethanamine
|
|
C9H18N2 |
详情 |
详情
|
(IV) |
27635 |
(2S)-4-amino-5-chloro-2-methyl-N-[2-tetrahydro-1H-pyrrolizin-7(5H)-ylethyl]-2,3-dihydro-1-benzofuran-7-carboxamide
|
|
C19H26ClN3O2 |
详情 |
详情
|
(V) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
(VII)
【1】
Zhao LQ,Zhao DM,Zhang YF.et al.2000.Synthesis of 2-adrenoceptor agonist formoterol.中国药物化学杂志,10 (4): 285 --287 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32763 |
1-[4-(benzyloxy)-3-nitrophenyl]-2-bromo-1-ethanone
|
|
C15H12BrNO4 |
详情 |
详情
|
(II) |
50312 |
(2R)-2-[4-(benzyloxy)-3-nitrophenyl]oxirane; benzyl 2-nitro-4-[(2R)oxiranyl]phenyl ether
|
|
C15H13NO4 |
详情 |
详情
|
(III) |
66383 |
1-(4-Methoxyphenyl)propan-2-amine |
50505-80-1 |
C10H15NO |
详情 | 详情
|
(IV) |
66384 |
1-(4-(benzyloxy)-3-nitrophenyl)-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethanol |
|
C25H28N2O5 |
详情 | 详情
|
(V) |
66385 |
1-(3-amino-4-(benzyloxy)phenyl)-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethanol hydrochloride |
|
C25H30N2O3.HCl |
详情 | 详情
|
(VI) |
66386 |
N-(2-(benzyloxy)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide hydrochloride |
|
C26H31ClN2O4 |
详情 | 详情
|
(VII) |
23808 |
Fumaric acid; (E)-2-butenedioic acid
|
110-17-8 |
C4H4O4 |
详情 | 详情
|